What is Lumexa Imaging Holdings, Inc. 's D&A?

Lumexa Imaging Holdings, Inc. (LMRI) reported D&A of $9.92M in Q1 2026.

Non-cash expense representing the systematic allocation of tangible asset costs (depreciation) and intangible asset costs (amortization) over their useful lives.

Lumexa Imaging Holdings, Inc. LMRI D&A

D&A at other companies

RadNetRDNT

$44.97M+26.7%

Labcorp HoldingsLH

$75.6M+8.6%

Quest DiagnosticsDGX

$37M-5.1%

Opko HealthOPK

$18.97M-4.5%

NovantaNOVT

$5.77M+4.0%

GE HealthCare TechnologiesGEHC

——

Other financials

Income statement

See full

Revenue$252.5M+3.1%

Operating income$19.4M-24.0%

Net income$1.7M+122%

EPS (diluted)$0.02+118%

Balance sheet

See full

Cash & equivalents$51.2M—

Total debt$965.8M—

Total equity$599.6M+272%

Total assets$1.8B—

Cash flow

See full

Operating cash flow$2.9M+121%

CapEx$5.3M+431%

Free cash flow-$2.4M+84.1%

Valuation

See full

Market cap$958.89M-45.3%

Enterprise value$1.87B—

Returns & leverage

See full

Debt / equity1.6×—

Current ratio1.4×—

Where this comes from

Reported directly by Lumexa Imaging Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:DepreciationAndAmortization.

The official record: Lumexa Imaging Holdings, Inc. ’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lumexa Imaging Holdings, Inc. 's d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Lumexa Imaging Holdings, Inc. 's D&A?: Lumexa Imaging Holdings, Inc. (LMRI) reported D&A of $9.92M in Q1 2026.
What does D&A mean?: Non-cash expense representing the systematic allocation of tangible asset costs (depreciation) and intangible asset costs (amortization) over their useful lives.